A detailed history of First Horizon Advisors, Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 159 shares of LIVN stock, worth $8,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159
Previous 64 148.44%
Holding current value
$8,264
Previous $3,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$51.76 - $64.15 $4,917 - $6,094
95 Added 148.44%
159 $8,000
Q4 2023

Feb 06, 2024

BUY
$43.45 - $53.66 $782 - $965
18 Added 39.13%
64 $3,000
Q1 2023

May 15, 2023

SELL
$40.84 - $58.14 $775 - $1,104
-19 Reduced 29.23%
46 $2,000
Q4 2022

Feb 10, 2023

SELL
$43.88 - $56.16 $10,531 - $13,478
-240 Reduced 78.69%
65 $3,000
Q2 2022

Aug 02, 2022

BUY
$57.25 - $86.63 $1,717 - $2,598
30 Added 10.91%
305 $19,000
Q1 2022

May 10, 2022

SELL
$71.02 - $86.99 $2,627 - $3,218
-37 Reduced 11.86%
275 $23,000
Q4 2021

Feb 09, 2022

SELL
$76.72 - $92.68 $153 - $185
-2 Reduced 0.64%
312 $27,000
Q3 2021

Nov 15, 2021

SELL
$76.02 - $88.62 $5,549 - $6,469
-73 Reduced 18.86%
314 $24,000
Q3 2021

Nov 09, 2021

BUY
$76.02 - $88.62 $26,454 - $30,839
348 Added 892.31%
387 $30,000
Q2 2021

Aug 09, 2021

BUY
$73.44 - $87.01 $660 - $783
9 Added 30.0%
39 $3,000
Q1 2021

May 11, 2021

BUY
$62.9 - $82.41 $1,887 - $2,472
30 New
30 $2,000
Q4 2019

Jan 07, 2020

SELL
$68.92 - $85.27 $151,624 - $187,594
-2,200 Closed
0 $0
Q2 2019

Aug 05, 2019

SELL
$66.45 - $97.36 $1,196 - $1,752
-18 Reduced 0.81%
2,200 $0
Q1 2019

Apr 26, 2019

BUY
$86.15 - $100.49 $191,080 - $222,886
2,218 New
2,218 $0

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.78B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.